Ataxia
Possible conditions
Friedreich's Ataxia: 3 Genes and 6 Biomarkers to Track
Living with Friedreich's ataxia — or supporting someone who does — means navigating a condition where the body's most fundamental energy machinery is under attack. It is not simply about coordination or balance.
Pes Cavus Genes Biomarkers — 5 Genes And 6 Biomarkers To Track
If you have pes cavus — a foot with an unusually high arch — you have probably been told to get custom orthotics, stretch your calves, and strengthen your intrinsic foot muscles. That advice is not wrong, but for a significant proportion of people with high-arched feet, it leaves out the most important question: why does your arch look the way it does?
Niemann-Pick Disease Genes and Biomarkers — 3 Genes And 5 Biomarkers To Track
Niemann-Pick disease is not a single condition. It is a group of inherited lysosomal storage disorders defined by a molecular failure in how the body processes specific fats — primarily sphingomyelin and cholesterol — at the cellular level.
Hereditary Spastic Paraplegia Genes and Biomarkers — 7 Genes and 6 Biomarkers to Track
Living with hereditary spastic paraplegia, or watching a family member navigate its progression, brings a particular kind of uncertainty. The condition moves slowly enough that it can feel manageable one year, then noticeably different the next.
Arthrogryposis Multiplex Congenita Genes Biomarkers - 7 Genes And 5 Biomarkers To Track
If you or someone in your family has a diagnosis of arthrogryposis multiplex congenita, one of the first things that becomes clear is how differently the condition presents from person to person. The number of joints involved, the pattern of contractures, whether muscle weakness is part of the picture, how much function can be recovered through early therapy — all of it varies in ways that standard descriptions of the condition rarely address.
Spinocerebellar Ataxia: 7 Genes and 6 Biomarkers to Track
Living with spinocerebellar ataxia places you in a frustrating paradox. The genetic cause is often precisely known — a specific gene, a specific repeat count, sometimes the exact size of the expansion — yet the clinical conversation frequently ends at "degenerative condition, supportive care only." That gap between molecular precision and practical guidance is real, and this article is an attempt to close some of it.
Guillain-Barré Syndrome: 5 Genes and 7 Biomarkers to Track
If you or someone close to you has been through Guillain-Barré syndrome, you already know that the standard advice — rest, physical therapy, "give it time" — doesn't answer the questions that actually keep you up at night.